Sonoma Pharmaceuticals Inc (SNOA)
NASDAQ
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 47.242 | -64.158 | -70.114 | -20.311 | -26.736 | -30.066 | -29.371 | -31.223 |
Return on Equity (%) | 58.75 | -77.961 | -91.404 | -30.697 | -56.156 | -72.347 | -61.785 | -68.514 |
Return on Invested Capital (%) | -57.768 | -84.075 | -101.99 | -79.142 | -59.379 | -85.048 | -66.668 | -81.568 |
Operating Margin (%) | -100.85 | -85.773 | -59.605 | -14.834 | -20.881 | -42.825 | -39.06 | -39.505 |
Net Profit Margin (%) | 72.312 | -86.013 | -62.193 | -15.558 | -21.203 | -40.276 | -38.811 | -37.966 |
Book Value Per Share | 2.531 | 1.481 | 1.91 | 1.462 | 0.855 | 1.195 | 0.876 | 0.31 |
Earnings Per Share | 1.095 | -1.384 | -2.148 | -0.495 | -0.63 | -0.699 | -0.565 | -0.244 |
Cash Per Share | 2.062 | 0.973 | 0.672 | 0.62 | 0.673 | 1.016 | 0.419 | 0.158 |
Working Capital Per Share | 2.286 | 1.255 | 1.621 | 1.263 | 1.42 | 1.458 | 1.106 | 0.446 |
Operating Profit Per Share | 0.699 | 0.754 | 1.699 | 1.452 | 1.082 | 0.574 | 0.505 | 0.249 |
EBIT Per Share | -1.528 | -1.384 | -2.064 | -0.474 | -0.622 | -0.744 | -0.569 | -0.254 |
EBITDA Per Share | -1.528 | -1.384 | -2.064 | -0.474 | -0.622 | -0.744 | -0.569 | -0.254 |
Free Cash Flow Per Share | 1.113 | -1.414 | -2.212 | -0.513 | -0.638 | -0.706 | -0.55 | -0.252 |
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 4,29M | 6,17M | 1,32M | 1,78M | 2,09M | 3,1M | 4,93M | N/A |
Fin d'année 31 Mars 2024 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 3,11M | 4,93M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | -42.34 | N/A | N/A | N/A | -29.401 | N/A |
Net Profit Margin (%) | N/A | N/A | -41.377 | N/A | N/A | N/A | -33.707 | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 3,6M |
Ratio cours/bénéfice | -0,74 |
Ratio prix/ventes | 0,28 |
Ratio prix/liquidités | 1,14 |
Ratio prix/valeur comptable | 0,58 |
Rendement de dividende | - |
Actions en circulation | 1,34M |
Volume moyen (1 semaine) | 42,92k |
Volume moyen (1 mois) | 289,94k |
Variation sur 52 semaines | -26,37% |
Plus haut sur 52 semaines | 9,374 |
Plus bas sur 52 semaines | 2,44 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales